# Development of a Live‐Cell Imaging Assay to Elucidate Spatiotemporal Dynamics of Extracellular Vesicle Fusion with Target Cells

**Authors:** Jasper van den Ende, Kyra A. Y. Defourny, Huib H. Rabouw, Marvin E. Tanenbaum, Richard W. Wubbolts, Esther N. M. Nolte‐‘t Hoen

PMC · DOI: 10.1002/jev2.70228 · Journal of Extracellular Vesicles · 2026-03-01

## TL;DR

A new live-cell imaging method tracks how extracellular vesicles fuse with target cells, helping understand how they deliver their contents.

## Contribution

A novel live-cell imaging assay called EV-FUSIM is developed to directly visualize and quantify extracellular vesicle fusion with target cells.

## Key findings

- EV-FUSIM enables real-time imaging of EV-binding, uptake, and fusion events.
- The method allows quantification of fusion kinetics and subcellular localization of fusion.
- The assay can identify fusogenic EV subsets and factors modulating fusion.

## Abstract

Cells communicate via extracellular vesicles (EVs) containing functional RNAs, proteins, and lipids. Knowledge on the fate of internalized EVs, especially their capacity to fuse with target cell membranes and deliver luminal cargo, is limited. Currently available EV‐cargo delivery assays are indirect and thus unlikely to uncover molecular players and conditions that specifically control the EV‐fusion step. Here, we present a novel live‐cell imaging assay for detection of EV‐binding, ‐uptake, and ‐fusion in time and space. We employed the SunTag system for exceptional signal amplification. EV‐donor cells were engineered to tag the luminal EV‐membrane with a fluorescent label coupled to SunTag peptides. Recipient cells express fluorescent single‐chain anti‐SunTag antibody (STAb), which binds EV‐enclosed SunTag upon its cytosolic exposure. Using SunTagged EVs carrying fusogen VSV‐G, we visualize the EV‐fusion process, quantify fusion kinetics and efficiency, and determine subcellular localization of fusion events. We term this methodology the Extracellular Vesicle Fusion Spatiotemporal Imaging Method (EV‐FUSIM). In the future, this technology can support the identification of fusogenic EV‐subsets, as well as molecular players and drugs that modulate EV‐fusion, without confounding effects of post‐fusion processes. This will extend knowledge on EV‐biology and can aid in the engineering of EVs that efficiently deliver intraluminal therapeutic payloads.

We present a novel live‐cell imaging assay for detection of extracellular vesicle (EV)‐binding, ‐uptake, and ‐fusion in time and space. Using EVs carrying the fusogen VSV‐G, we demonstrate real‐time imaging of EV‐fusion, quantification of fusion kinetics and efficiency, and subcellular localization of fusion events. In the future, this technology can support the identification of fusogenic EV‐subsets and factors controlling EV‐fusion. This will extend knowledge on EV‐biology and can aid in the engineering of EVs that efficiently deliver intraluminal therapeutic payloads.

## Full-text entities

- **Genes:** Canx (calnexin) [NCBI Gene 12330] {aka 1110069N15Rik, Cnx, D11Ertd153e}, PALM (paralemmin) [NCBI Gene 5064] {aka PALM1}, CD63 (CD63 molecule) [NCBI Gene 967] {aka AD1, HOP-26, ME491, MLA1, OMA81H, Pltgp40}, MAG (myelin associated glycoprotein) [NCBI Gene 4099] {aka GMA, S-MAG, SIGLEC-4A, SIGLEC4, SIGLEC4A, SPG75}, Cd63 (CD63 antigen) [NCBI Gene 12512] {aka ME491, Tspan30}, CD9 (CD9 molecule) [NCBI Gene 928] {aka BTCC-1, DRAP-27, MIC3, MRP-1, TSPAN-29, TSPAN29}, LGALS3 (galectin 3) [NCBI Gene 3958] {aka CBP35, GAL3, GALBP, GALIG, L31, LGALS2}, LDLR (low density lipoprotein receptor) [NCBI Gene 3949] {aka LDLCQ2}, Cd9 (CD9 antigen) [NCBI Gene 12527] {aka Tspan29}, RNF112 (ring finger protein 112) [NCBI Gene 7732] {aka BFP, ZNF179}
- **Diseases:** cervical carcinoma (MESH:D002583), Spin (MESH:D014717), infection (MESH:D007239)
- **Chemicals:** beta-galactosides (MESH:C007816), bromophenol blue (MESH:D001978), polyacrylamide (MESH:C016679), streptomycin (MESH:D013307), Triton X-100 (MESH:D017830), sodium deoxycholate (MESH:D003840), sodium chloride (MESH:D012965), Optiprep (MESH:C044834), MgCl2 (MESH:D015636), dodecyl sulfate (MESH:C028913), BafA1 (MESH:C040929), SDS (MESH:D012967), CFSE (MESH:C087165), glycine (MESH:D005998), luminal (MESH:D010634), TBS (MESH:D013725), Hoechst 33342 (MESH:C017807), Lipofectamine 2000 (MESH:C086724), oil (MESH:D009821), 2-mercaptoethanol (MESH:D008623), TCA (MESH:D014238), phenol red (MESH:D010637), LysoTracker (MESH:C493330), CellMask (-), HEPES (MESH:D006531), penicillin (MESH:D010406), puromycin (MESH:D011691), glycerol (MESH:D005990), PVDF (MESH:C024865), Tween-20 (MESH:D011136), TBS-T (MESH:C027647), PBS (MESH:D007854), NLS (MESH:D019913), Ca (MESH:D002118), DMSO (MESH:D004121), Mg (MESH:D008274), glucose (MESH:D005947), CO2 (MESH:D002245), lipid (MESH:D008055), polybrene (MESH:D006583)
- **Species:** Lentivirus (genus) [taxon 11646], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Danio rerio (leopard danio, species) [taxon 7955], Vesicular stomatitis virus (species) [taxon 11276], Drosophila melanogaster (fruit fly, species) [taxon 7227]
- **Mutations:** S10A, P127D, proline amino acid at position 127
- **Cell lines:** HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), HeLa Gal3 — Homo sapiens (Human), Lung large cell carcinoma, Cancer cell line (CVCL_2T27), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), mScar3 — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_C0CY), -2 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_A628), HeLa R19 — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_M763), HeLa palm — Rhynchophorus ferrugineus (Red palm weevil), Spontaneously immortalized cell line (CVCL_A2PS), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12949999/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12949999/full.md

## References

74 references — full list in the complete paper: https://tomesphere.com/paper/PMC12949999/full.md

---
Source: https://tomesphere.com/paper/PMC12949999